Infections cast cloud over Novartis' MS therapy.
Garber
Ken
K
D004345:Drug Industry; D000068876:Fingolimod Hydrochloride; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014777:Virus Diseases / Q000150:complications*
D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine